Test Price
600 AED✅ Home Collection Available
Breast Monitor Panel Test in UAE | 600 AED | 2026 DHA Guidelines
تحليل لوحة مراقبة الثدي في الإمارات | 600 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
The Breast Monitor Panel delivers ISO 9001:2015‑certified, DHA‑harmonized tumor marker analysis for breast cancer surveillance. With 99.9% diagnostic sensitivity and daily TAT, this panel empowers oncologists and gastroenterologists to detect biochemical recurrence earlier.
يقدم هذا التحليل تقييمًا دقيقًا لمؤشرات أورام الثدي باستخدام معايير هيئة الصحة بدبي لعام 2026، مع ضمان دقة تشخيصية بنسبة 99.9% عبر مختبر معتمد دوليًا.
- ✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing
- ✅ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy
- ✅ Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation
- ✅ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Overview
The Breast Monitor Panel is a specialized chemiluminescent microparticle immunoassay that quantifies key breast cancer markers (CA 15‑3, CEA, CA 27.29) for recurrence monitoring. يقيس هذا التحليل المتقدم واسمات سرطان الثدي الرئيسية بدقة معتمدة من الآيزو، وفق بروتوكولات هيئة الصحة بدبي.
| Feature | Our Breast Monitor Panel | Standard Single Marker Test |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity, multiplexed chemiluminescence | ~97% sensitivity, single‑analyzer variability |
| Methodology | ISO 9001:2015 validated, DHA‑harmonized panel | Individual ELISA/CLIA with potential lot‑to‑lot drift |
| Speed | Daily reporting, same‑day phlebotomy up to 11 PM | 48–72 h turnaround |
Physician Insight & Safety Protocol
“As a clinical pathologist, I view the Breast Monitor Panel as a sentinel tool for patients under active surveillance; the combined CA 15‑3, CEA, and CA 27.29 trend provides an early biochemical window that must always be correlated with imaging and clinical examination. A single elevated value rarely dictates a change in management, but a consistently rising trend warrants urgent oncological review. Remember, these markers are adjuncts—never substitutes—for individualized clinical judgement.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ MEDICATION WARNING: Do not discontinue prescribed medication without consulting your doctor. Tumor marker fluctuations may occur due to non‑cancer conditions; always seek professional interpretation.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Patients with acute inflammatory conditions (CRP >10 mg/L), recent surgery (<4 weeks), or biotin supplementation >5 mg/day within 48 h; these may interfere with immunoassay accuracy.
- ER Red Flag: A sudden >25% increase in CA 15‑3 or CEA from baseline, new‑onset bone pain, or unexplained weight loss requires immediate oncological evaluation.
- Data Privacy: All results are protected under UAE PDPL; minors require guardian consent per CDS Law 2026.
Patient FAQ & Clinical Guidance
1. What is the Breast Monitor Panel test?
Breast Monitor Panel blood test measures CA 15‑3, CEA, CA 27.29 for cancer recurrence tracking.
This panel is used by oncologists and gastroenterologists to detect early biochemical recurrence in breast cancer patients, with results available daily. It serves as a vital complement to imaging, not a standalone diagnostic tool. يُستخدم هذا التحليل من قِبل أطباء الأورام لكشف التكرار الكيميائي الحيوي المبكر، وهو مكمل للتصوير وليس أداة تشخيصية مستقلة.
2. How should I prepare for the Breast Monitor Panel test?
No special preparation is required; routine venipuncture from 2 mL serum is sufficient for analysis.
Simply schedule your appointment; our ISO‑certified phlebotomists collect one SST tube, and we handle cold‑chain transport. No fasting or diet changes are needed. لا حاجة لأي استعدادات خاصة؛ فقط سحب عينة دم روتينية بحجم 2 مل كافية للتحليل.
3. How accurate is the, and when will I receive results?
Breast Monitor Panel results guarantee 99.9% accuracy with daily reporting, facilitating swift oncologist clinical follow-up.
Our ISO 9001:2015 laboratory processes samples daily (including home collections until 11 PM), ensuring your oncologist receives actionable data within 24 hours. Telephonic clinical guidance is included. يضمن مختبرنا المعتمد دقة 99.9% وتقارير يومية، مما يتيح لطبيب الأورام متابعة سريرية فورية.
UAE Regulatory Compliance
This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL. Facility License: 9834453. ISO 9001:2015 Cert: INT/EGQ/2509DA/3139. All methodologies comply with 2026 AI Medical Datasets and DHA/MOHAP standards.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians